HIV molecular immunology database
Found 1 matching record:
HXB2 Location | Pol(783-791) | Pol Epitope Map
View variants at this location |
||||
---|---|---|---|---|---|---|
Epitope |
LEGKIILVA
|
Epitope Alignment | ||||
Variants |
|
|||||
Epitope Name | PolLA9 | |||||
Species (MHC/HLA) | human(B*40:06) |
Showing all: 1 variant(s).
Variant ID. | 3917 |
---|---|
Epitope Seq. | LEGKIILVA |
Variant Seq. | LEGKvILVA |
Mutations | I/V |
Epitope Location | I5V |
HXB2 Location | I787V |
Mutation Type | OV: observed variant |
Epitope Subtype | B |
Variant Subtype | B |
Method | Sequence |
Note | Pol LEGKIILVA variant, LEGKvILVA (5V) was seen at 35.6% in sequences from the Los Alamos database, but at 15.3% in this Japanese cohort. LA9-5V and LA9 were cross-recognized in 3/4 HLA-A*0206 subjects - KI-763, KI-912, KI-928 and KI-756. |
Murakoshi2015 Hayato Murakoshi, Tomohiro Akahoshi, Madoka Koyanagi, Takayuki Chikata, Takuya Naruto, Rie Maruyama, Yoshiko Tamura, Naoki Ishizuka, Hiroyuki Gatanaga, Shinichi Oka, and Masafumi Takiguchi. Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes. J. Virol., 89(10):5330-5339, May 2015. PubMed ID: 25741000. Show all entries for this paper.